Medical Innovation Exchange

'The Top Line': A closer look at European biotech investment in 2024

This week on “The Top Line,” we explore the European biotech investment landscape. 

Fierce Biotech’s James Waldron sits down with Maina Bhaman, a Partner at Sofinnova Capital Strategy, who provides insights into how investors are approaching the European biotech sector. 

To learn more about the topics in this episode: 

https://www.fiercebiotech.com/biotech/top-line-closer-look-european-biotech-investment-2024

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!